Rapid Nutrition PLC Half-Year Report of Liquidity Contract as at 31/12/2023
Rapid Nutrition PLC (Ticker: ALRPD) is pleased to announce the release of its Half Year Report on Liquidity Contract as at 31 December 2023 with TSAF-Tradition Securities and Futures to promote regular trading and liquidity of the shares of RAPID NUTRITION. The Half Year Report provides a comprehensive overview of the company's liquidity position as of 31 December 2023.
This liquidity contract complies with the current legal framework, and more particularly with the provisions of Regulation (EU) No.596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse and Regulation (EU) 2016/908 that complements the MAR Regulation, L.225-209 and following of the Commercial Code and the decision AMF No.2018-01 of July 2, 2018, applicable as of January 1, 2019, with the establishment of contracts of liquidity on equity securities. In accordance with accepted market practices together with all other provisions mentioned therein.
TSAF operates in the regulated markets, covering both equities and derivative products. It is a member of all the major regulated markets in Europe and the United States, with access to the principal sources of liquidity. The Company's teams are based in Paris and London. TSAF OTC is a Paris-based specialist in OTC (over-the-counter) markets, offering customers substantial liquidity in a very broad range of products. TSAF and TSA.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).